cells tumor-immune mice vitro retain specific function vitro leukemia vivo therapeutic efficacy adoptive immunotherapy cancer dose tumor-immune cells success therapy dependent ability large numbers active cells Previous studies animal models limited therapeutic efficacy small number immune cells expansion cells vitro numbers transfer vivo Optimal regimens cell expansion vitro use intermittent stimulation TCR specific Ag exogenous use requisite episodic up-regulation Stimulation invariant portion complex antibody alternative method up-regulating growth Ag-specific cell lines clones long-term vitro maintenance function specificity current study cell populations small numbers memory tumor-specific cells effective tumor therapy nonspecific expansion vitro plus Spleens mice syngeneic virus-induced leukemia plus resultant cells number nonlytic ability lytic specific stimulation effective specific tumor therapy Ag-specific anti-tumor immune function per cell basis cycle cell expansion approach substantial increase total cell number overall net increase function effector cell population stimulation tumor-immune cell populations nonspecific method number specific effector cells cancer therapy 